2018年
- ASO Author Reflections: ARL4C and Peritoneal Dissemination in Gastric Cancer.
Hu Q, Mimori K.
Ann Surg Oncol. 2018 Dec 17. doi: 10.1245/s10434-018-7056-7. [Epub ahead of print] No abstract available.
PMID: 30556117 - Cytolytic Activity (CYT) Score Is a Prognostic Biomarker Reflecting Host Immune Status in Hepatocellular Carcinoma (HCC).
Wakiyama H, Masuda T, Motomura Y, Hu Q, Tobo T, Eguchi H, Sakamoto K, Hirakawa M, Honda H, Mimori K.
Anticancer Res. 2018 Dec;38(12):6631-6638. doi: 10.21873/anticanres.13030.
PMID: 30504371 - Cancer evolution and heterogeneity.
Mimori K, Saito T, Niida A, Miyano S.
Ann Gastroenterol Surg. 2018 Jul 4;2(5):332-338. doi: 10.1002/ags3.12182. eCollection 2018 Sep. Review.
PMID: 30238073 - 食道癌のゲノム医療
大津甫, 三森功士
雑誌『外科』 80巻12号(2018年11月号) - Prognostic Impact of Immune-Related Gene Expression in Preoperative Peripheral Blood from Gastric Cancer Patients.
Ito S, Fukagawa T, Noda M, Hu Q, Nambara S, Shimizu D, Kuroda Y, Eguchi H, Masuda T, Sato T, Katai H, Sasako M, Mimori K.
Ann Surg Oncol. 2018 Sep 10. doi: 10.1245/s10434-018-6739-4. [Epub ahead of print]
PMID: 30203407 - Serial mutational tracking in surgically resected locally advanced colorectal cancer with neoadjuvant chemotherapy.
Sugimachi K, Sakimura S, Kuramitsu S, Hirata H, Niida A, Iguchi T, Eguchi H, Masuda T, Morita M, Toh Y, Maehara Y, Suzuki Y, Mimori K.
Br J Cancer. 2018 Aug;119(4):419-423. doi: 10.1038/s41416-018-0208-5. Epub 2018 Aug 3.
PMID: 30072744 - Circulating Pre-microRNA-488 in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer.
Masuda T, Shinden Y, Noda M, Ueo H, Hu Q, Yoshikawa Y, Tsuruda Y, Kuroda Y, Ito S, Eguchi H, Ohno S, Mimori K.
Anticancer Res. 2018 Aug;38(8):4515-4523. doi: 10.21873/anticanres.12755.
PMID: 30061217 - A temporal shift of the evolutionary principle shaping intratumor heterogeneity in colorectal cancer.
Saito T, Niida A, Uchi R, Hirata H, Komatsu H, Sakimura S, Hayashi S, Nambara S, Kuroda Y, Ito S, Eguchi H, Masuda T, Sugimachi K, Tobo T, Nishida H, Daa T, Chiba K, Shiraishi Y, Yoshizato T, Kodama M, Okimoto T, Mizukami K, Ogawa R, Okamoto K, Shuto M, Fukuda K, Matsui Y, Shimamura T, Hasegawa T, Doki Y, Nagayama S, Yamada K, Kato M, Shibata T, Mori M, Aburatani H, Murakami K, Suzuki Y, Ogawa S, Miyano S, Mimori K.
Nat Commun. 2018 Jul 23;9(1):2884. doi: 10.1038/s41467-018-05226-0.
PMID: 30038269 Free PMC Article - Overexpression of FGFR1 Promotes Peritoneal Dissemination Via Epithelial-to-Mesenchymal Transition in Gastric Cancer.
Shimizu D, Saito T, Ito S, Masuda T, Kurashige J, Kuroda Y, Eguchi H, Kodera Y, Mimori K.
Cancer Genomics Proteomics. 2018 Jul-Aug;15(4):313-320. doi: 10.21873/cgp.20089.
PMID: 29976636 - Identification of UHRF2 as a Negative Regulator of Epithelial-Mesenchymal Transition and Its Clinical Significance in Esophageal Squamous Cell Carcinoma.
Iguchi T, Ueda M, Masuda T, Nambara S, Kidogami S, Komatsu H, Sato K, Tobo T, Ogawa Y, Hu Q, Saito T, Hirata H, Sakimura S, Uchi R, Hayashi N, Ito S, Eguchi H, Sugimachi K, Maehara Y, Mimori K.
Oncology. 2018 Jun 15:1-9. doi: 10.1159/000488860. [Epub ahead of print]
PMID: 29909415 - PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer.
Kiyozumi Y, Iwatsuki M, Kurashige J, Ogata Y, Yamashita K, Koga Y, Toihata T, Hiyoshi Y, Ishimoto T, Baba Y, Miyamoto Y, Yoshida N, Yanagihara K, Mimori K, Baba H.
Int J Cancer. 2018 Mar 30. doi: 10.1002/ijc.31410. [Epub ahead of print]
PMID: 29603227 - GWAS identifies two novel colorectal cancer loci at 16q24.1 and 20q13.12.
Tanikawa C, Kamatani Y, Takahashi A, Momozawa Y, Leveque K, Nagayama S, Mimori K, Mori M, Ishii H, Inazawa J, Yasuda J, Tsuboi A, Shimizu A, Sasaki M, Yamaji T, Sawada N, Iwasaki M, Tsugane S, Naito M, Wakai K, Koyama T, Takezaki T, Yuji K, Murakami Y, Nakamura Y, Kubo M, Matsuda K.
Carcinogenesis. 2018 May 3;39(5):652-660. doi: 10.1093/carcin/bgy026.
PMID: 29471430 - Clinicopathological characteristics of disseminated carcinomatosis of the bone marrow in breast cancer patients.
Shinden Y, Sugimachi K, Tanaka F, Fujiyoshi K, Kijima Y, Natsugoe S, Mimori K.
Mol Clin Oncol. 2018 Jan;8(1):93-98. doi: 10.3892/mco.2017.1502. Epub 2017 Nov 15.
PMID: 29423222 - Understanding intratumor heterogeneity by combining genome analysis and mathematical modeling.
Niida A, Nagayama S, Miyano S, Mimori K.
Cancer Sci. 2018 Apr;109(4):884-892. doi: 10.1111/cas.13510. Epub 2018 Feb 28. Review.
PMID: 29352488 - Preventive and promotive effects of habitual hot spa-bathing on the elderly in Japan.
Maeda T, Mimori K, Suzuki S, Horiuchi T, Makino N.
Sci Rep. 2018 Jan 9;8(1):133. doi: 10.1038/s41598-017-18488-3.
PMID: 29317745 - Combined Mutation of Apc, Kras, and Tgfbr2 Effectively Drives Metastasis of Intestinal Cancer.
Sakai E, Nakayama M, Oshima H, Kouyama Y, Niida A, Fujii S, Ochiai A, Nakayama KI, Mimori K, Suzuki Y, Hong CP, Ock CY, Kim SJ, Oshima M.
Cancer Res. 2018 Mar 1;78(5):1334-1346. doi: 10.1158/0008-5472.CAN-17-3303. Epub 2017 Dec 27.
PMID: 29282223 - Identification of ARL4C as a Peritoneal Dissemination-Associated Gene and Its Clinical Significance in Gastric Cancer.
Hu Q, Masuda T, Sato K, Tobo T, Nambara S, Kidogami S, Hayashi N, Kuroda Y, Ito S, Eguchi H, Saeki H, Oki E, Maehara Y, Mimori K.
Ann Surg Oncol. 2018 Mar;25(3):745-753. doi: 10.1245/s10434-017-6292-6. Epub 2017 Dec 21.
PMID: 29270876